Print Mode Enable Media Only

News chronological

10 items before 1086400

NYTIMES (Hilary Howard and Olivia Bensimon) - Pollution Worsened in South Bronx After Congestion Tolls, Study Finds

Columbia University researchers said that sensors detected a 2 percent increase in toxic particles in the air. M.T.A. officials disputed the report.

NYTIMES (Santul Nerkar) - Trial Begins for Man Accused of Running Secret Police Outpost for China

Lu Jianwang, a U.S. citizen, is accused of working on behalf of the Chinese government to target dissidents. A co-defendant has pleaded guilty.

NYTIMES (Jonathan Wolfe) - Guy Goma’s Accidental BBC Interview Lives On After 20 Years

Guy Goma thought he was interviewing for an I.T. job when he found himself on air on the BBC. What came next was familiar to anyone who has been unprepared at work.

NYTIMES (Farah Stockman) - American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.

A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the World Economic Forum this year.

NYTIMES (Lara Jakes and Andrada Lautaru) - In Romania, Living With Weapons of War Spilling Into NATO Territory

Four years of battle in Ukraine is taking a toll on neighboring Romanians. Even if the war has not crossed the border, drones have done so.

NYTIMES (Tariq Panja, Emma Bubola, Lucía Cholakian Herrera and Sarah Pabst) - World Cup Dynamic Ticket Pricing Drives Argentine Soccer Fans To Extremes

Dynamic ticket pricing has made this year’s tournament the most expensive in history, pushing Argentine fans to extremes.

NYTIMES (Danny Hakim) - A Look Inside the Case That Enshrined Political Power for Billionaires

After Watergate, Congress tried to curtail the role of money in politics. But a pivotal Supreme Court case nipped it in the bud. Years later, new details are emerging on how wealthy Americans were conferred with a “right to spend” on elections.

NYTIMES (Pam Belluck) - Tofersen, a New Treatment for A.L.S., Reverses Symptoms for Some

The drug is for a small subset of patients. But evidence that breathing and strength can get better for some of them is remarkable for a paralyzing, usually fatal disease.